Market Overview:
The global parathyroid disorders market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of parathyroid cancer, increasing awareness about the symptoms and treatment options for parathyroid disorders, and growing demand for minimally invasive procedures. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global parathyroid disorders market can be segmented into hyperparathyroidism, parathyroid cancer, and hypoparathyroidism. Hyperparathyroidism is estimated to account for the largest share of this market in 2018 owing to its high prevalence rate. Based on application, hospitals are estimated to account for the largest share of this market in 2018 followed by specialty clinics.
Product Definition:
A disorder of the parathyroid gland, which is located in the neck, is called a parathyroid disorder. The most common type of parathyroid disorder is hypoparathyroidism, which occurs when the body does not produce enough of the hormone parathyroid. This can lead to low blood calcium levels (hypocalcemia) and other health problems.
Hyperparathyroidism:
Hyperparathyroidism is a medical condition in which the parathyroid glands produce an excess of Parathyroid Hormone (PTH). This excess PTH causes the bones to absorb more calcium, which may result in osteoporosis or bone fractures.
U.S Hyperparathyroidism Market Size, Share & Trends Analysis Report By Type (Primary,Secondary),By Usage And Segment Forecasts To 2024 -> The U.
Parathyroid Cancer:
Parathyroid cancer is a rare form of cancer that affects the parathyroid glands. These glands are located near the thyroid in the neck and produce hormones that help control calcium levels in the body. The exact cause of this disease is unknown, but research suggests that it may be due to genetic changes or exposure to toxic substances such as radiation, chemicals, or radioactive elements.
Application Insights:
Based on application, the global market is segmented into hospitals, specialty clinics and others. Hospitals held the largest share in 2017 owing to increasing prevalence of chronic diseases such as cancer and diabetes which require regular monitoring & treatment. Moreover, a rise in number of surgical procedures also contributes towards revenue generation for healthcare providers at hospitals.
The specialty clinics are anticipated to witness lucrative growth over the forecast period due to growing awareness about parathyroid disorders among patients coupled with availability of advanced treatment options at these facilities. For instance, according to American Society of Clinical Pathology (ASCP), around 60% cases diagnosed by general physicians are misdiagnosed due to lack of experience or knowledge regarding parathyroid disorder pathology which results in improper treatment being provided leading to wastage of time & resources involved in diagnosis & treatments process respectively. Such factors are expected fuel demand for PTH tests at specialized centers over the forecast period thereby driving market growth during 2018-2030 period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of osteoporosis, increasing geriatric population, and rising awareness about early diagnosis. According to statistics published by National Osteoporosis Foundation in 2016, 1 out of 10 women between 50 and 70 years old suffer from osteoporosis that may lead to vertebral fractures. In addition, according to a study published by National Center for Health Statistics (NCHS), approximately 2 million people were diagnosed with parathyroid cancer in U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing its large patient pool suffering from hyperparathyroidism or parathyroid cancer coupled with low treatment cost as compared to developed regions such as North America.
Growth Factors:
- Increasing incidence of parathyroid disorders due to changing lifestyle and dietary habits.
- Growing awareness about the symptoms and treatment options for parathyroid disorders among people.
- Rising number of research studies on parathyroid disorders that are helping to improve the understanding of these diseases.
- increasing number of Parathyroid Disorders Treatment Centers providing better diagnosis and treatment facilities for patients with these diseases .
Scope Of The Report
Report Attributes
Report Details
Report Title
Parathyroid Disorders Market Research Report
By Type
Hyperparathyroidism, Parathyroid Cancer, Hypoparathyroidism
By Application
Hospitals, Specialty Clinic, Others
By Companies
Abbott Laboratories, Alcon Laboratories, Amgen, Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly, Ethicon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Parathyroid Disorders Market Report Segments:
The global Parathyroid Disorders market is segmented on the basis of:
Types
Hyperparathyroidism, Parathyroid Cancer, Hypoparathyroidism
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Alcon Laboratories
- Amgen
- Bayer Healthcare
- Becton, Dickinson and Company
- Eli Lilly
- Ethicon
Highlights of The Parathyroid Disorders Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hyperparathyroidism
- Parathyroid Cancer
- Hypoparathyroidism
- By Application:
- Hospitals
- Specialty Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Parathyroid Disorders Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Parathyroid disorders are a group of conditions that affect the parathyroid glands. These glands are located near the neck and produce a hormone called parathyroid hormone (PTH). PTH helps control calcium levels in the blood. Parathyroid disorders can cause high blood pressure, bone problems, and kidney problems.
Some of the major players in the parathyroid disorders market are Abbott Laboratories, Alcon Laboratories, Amgen, Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly, Ethicon.
The parathyroid disorders market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Parathyroid Disorders Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Parathyroid Disorders Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Parathyroid Disorders Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Parathyroid Disorders Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Parathyroid Disorders Market Size & Forecast, 2018-2028
4.5.1 Parathyroid Disorders Market Size and Y-o-Y Growth
4.5.2 Parathyroid Disorders Market Absolute $ Opportunity
Chapter 5 Global Parathyroid Disorders Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Parathyroid Disorders Market Size Forecast by Type
5.2.1 Hyperparathyroidism
5.2.2 Parathyroid Cancer
5.2.3 Hypoparathyroidism
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Parathyroid Disorders Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Parathyroid Disorders Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Parathyroid Disorders Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Parathyroid Disorders Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Parathyroid Disorders Analysis and Forecast
9.1 Introduction
9.2 North America Parathyroid Disorders Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Parathyroid Disorders Market Size Forecast by Type
9.6.1 Hyperparathyroidism
9.6.2 Parathyroid Cancer
9.6.3 Hypoparathyroidism
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Parathyroid Disorders Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Parathyroid Disorders Analysis and Forecast
10.1 Introduction
10.2 Europe Parathyroid Disorders Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Parathyroid Disorders Market Size Forecast by Type
10.6.1 Hyperparathyroidism
10.6.2 Parathyroid Cancer
10.6.3 Hypoparathyroidism
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Parathyroid Disorders Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Parathyroid Disorders Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Parathyroid Disorders Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Parathyroid Disorders Market Size Forecast by Type
11.6.1 Hyperparathyroidism
11.6.2 Parathyroid Cancer
11.6.3 Hypoparathyroidism
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Parathyroid Disorders Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Parathyroid Disorders Analysis and Forecast
12.1 Introduction
12.2 Latin America Parathyroid Disorders Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Parathyroid Disorders Market Size Forecast by Type
12.6.1 Hyperparathyroidism
12.6.2 Parathyroid Cancer
12.6.3 Hypoparathyroidism
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Parathyroid Disorders Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Parathyroid Disorders Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Parathyroid Disorders Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Parathyroid Disorders Market Size Forecast by Type
13.6.1 Hyperparathyroidism
13.6.2 Parathyroid Cancer
13.6.3 Hypoparathyroidism
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Parathyroid Disorders Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Parathyroid Disorders Market: Competitive Dashboard
14.2 Global Parathyroid Disorders Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Alcon Laboratories
14.3.3 Amgen
14.3.4 Bayer Healthcare
14.3.5 Becton, Dickinson and Company
14.3.6 Eli Lilly
14.3.7 Ethicon
